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If it were possible  to promote or suspend  the formation of specifically  sensitized 
lymphocytes (activated T  cells),  the  problems of achieving a  sustained  attack on 
tumor cells and microbial parasites, or of preventing graft rejection, might be largely 
overcome. Methods for manipulating the immune response for such purposes have 
been proposed from time to time (1-3), but progress has been slow because so little 
is known of how cell-mediated  immunity is normally regulated. Although much has 
been learned about the allied  problem cf what controls the formation of antibodies 
(4), almost nothing is known about the mechanism that regulates the production and 
function of the cells which mediate delayed-type hypersensitivity (DTH).I 
While studying the tumor-suppressive activity of Mycobacterium boris  BCG 
it was observed that  lymphoid tissues which  were under  the  stimtflatory in- 
fluence of a BCG infection were capable of a much more vigorous response to a 
second antigen  (5).  Both  cellular  and  humoral immunity to  sheep red  blood 
cells (SRBC) were augmented, as evidenced by higher and more sustained levels 
(DTH)  and  increased  numbers  of plaque-forming cells  (PFC)  in  responding 
lymph nodes. Since DTH does not usually appear unless special conditions of 
immunization are used, these findings suggested that the formation of activated 
T  cells is normally restricted by an inhibitory mechanism that does not operate 
properly in lymphoid tissues infected with BCG. 
Miller  et  al.  (5)  have  shown  that  mice given  a  subcutaneous  injection  of 
SRBC  in  saline  develop  a  poorly  sustained  state  of  hypersensitivity which 
conforms  to  all  of  the  established  criteria  by which  DTH is  recognized,  in- 
cluding its mediation by 0-bearing lymphocytes. It was therefore possible to 
study  the  mechanism which  regulates  T-cell  activity in  the  absence  of  any 
influence  from  adjuvants  such  as  were  used  by  Nelson  and  Mildenhall  (6) 
when they, too, showed that mice develop classical DTH in response to SRBC. 
* This work has been supported by grant NIH-NCI-E-72-3221 from the National Cancer 
Institute,  and grant AI-07015 from the National Institute of Allergy and Infectious Diseases, 
National Institutes  of Health. 
Research Fellow, Eli Lilly Foundation, Indianapolis, Ind. 
1Abbreviations used in  this paper: DTH,  delayed-type  hypersensitivity;  PFC,  plaque- 
forming cells; SRBC, sheep red blood cells. 
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Materials and Methods 
Animals.--Specific pathogen-free,  outbred mice (CD-1 strain from Charles River Breeding 
Laboratories, Inc., Wilmington, Mass.)  were used at 4-6 wk of age. They were maintained 
on Sanicel bedding (R & E Feed Co., Troy, N. Y.), fed a vitamin-supplemented diet (Agway, 
Inc., Country Foods Div., Syracuse, N. Y.), and were segregated under Isocaps (Lab Cages, 
Inc., Kennett Square,  Pa.). 
Antigen.--SRBC  were  obtained from  one  animal which  was  bled at weekly intervals. 
Blood was collected into Alsever's solution,  and was stored at 4°C. The cells were washed 
three times before  use  and were  finally suspended  at the desired  concentration in normal 
saline. 
Measurement of Lymphoproliferati~'e Responses in the Popliteal Lymph Node.--The rate of 
cell division in popliteal lymph nodes responding to immunization by footpad inoculation of 
SRBC was measured in terms of thymidine incorporation into DNA. The method has been 
described previously (5). 
Test for Delayed-Type Hypersensitivity.--Hypersensitivity was measured  as the increase in 
footpad thickness 24 h after injecting an ellciting dose of 1 X  l0  s washed SRBC in a volume 
of 40/zl. The characteristics of the hypersensitivity measured in this way have also been de- 
scribed (5). As before, reactions were conventionally recorded against the day when the test 
dose of antigen was injected, rather than the day upon which the reaction was measured. 
Assay for Plaque-Forming Cells.--PFC were assayed by local hemolysis in gel (5). 
Splenectomy.--Splenectomized mice were prepared 3 wk before an experiment by removing 
the spleen through a flank incision. The spleen was dissected from its pedicle and excised with- 
out attempting to prevent bleeding. The wound was closed by Mischel clips. 
RESULTS 
The Effect of Antigen Dose on the Induction of DTH.--It was known from the 
early studies of Salvin (7) and of Uhr et al. (8) that dose and route of injection 
have  a  marked  effect upon  whether  or not  an  immunological stimulus  gives 
rise to delayed-type hypersensitivity (9). When varying doses of SRBC  were 
injected intravenously or into one  hind footpad,  two  different but highly re- 
producible patterns of response were found (Fig. 1).  For reasons that will be- 
come apparent, hypersensitivity was measured on day 4  in the intravenously 
sensitized mice  and  on  day  5  in  animals  sensitized by  footpad  inoculation. 
Maximum DTH  was achieved with a  dose of 105 SRBC  in intravenously im- 
munized  mice.  This  was  100-fold  less  than  the  dose  which  gave  maximum 
sensitization by footpad inoculation. Moreover, DTH  was sharply reduced in 
animals receiving more than the optimal intravenous dose. This suggested that 
production or function of activated T  cells might be blocked by excess antigen. 
The  concept of "desensitization" is often invoked to explain loss of DTH  in 
animals injected repeatedly with antigen. It implies that the mediators of DTH 
can be neutralized by antigen. The experiment recorded in Fig. 2  denies this 
as a possible explanation: Animals which had been immunized simultaneously 
by intravenous and footpad injections of l0  s SRBC displayed almost no DTH 
when tested on day 5  (group C); but animals which received only the footpad 
injection of SRBC  (group A) lost none of their hypersensitivity as a  result of 
receiving an intravenous injection of l0  s SRBC  on day 4, one full day before 
testing (group D). Indeed, the desensitized animals gave slightly greater  teat- y
tions (compare groups A and D). Animals of the other two groups in Fig. 2 
demonstrate again that an intravenous dose of 10 s SRBC produced very little 
hypersensitivity (group B), and that unsensitized mice did not react to the 
eliciting dose of SRBC (group E). 
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Fro. 1. Levels of delayed-type hypersensitivity generated in response to varying doses of 
SRBC. Antigen was administered either intravenously or into one hind footpad, and reactions 
were measured on days 4 and 5, respectively. Means of 5 -4- SE. 
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FIG. 2. Levels of DTH elicited in the left hind footpad of mice immunized with l0 s SRBC 
by inoculation of the right hind footpad only (group A), by intravenous injection only (group 
B), by footpad and intravenous injection (group C), or by footpad inoculation followed by an 
intravenous injection of 10 s SRBC on day 4 (group D). Animals of group E represent un- 
sensitized controls. Footpad reactions were elicited on day 5 and read on day 6. Means of 
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Kinetics of the Immune Response  to SRBC.--As desensitization did not seem 
to offer an explanation for the low levels of hypersensitivity displayed by heav- 
ily immunized animals, it had to be considered possible that excess  antigen 
inhibits DTH by suppressing the proliferation of T cells. To examine this ques- 
tion, cellular proliferation rates were measured in popliteal lymph nodes re- 
sponding to varying doses of SRBC, the resulting levels of DTH being followed 
in parallel. Sensitizing and eliciting injections of SRBC were given in opposite 
hind paws, and separate groups of mice were used on successive days to meas- 
ure DTH and thymidine incorporation into DNA. 
Fig. 3 shows a dose-dependent increase in the rate of thymidine incorporation 
into DNA in lymph nodes responding to varying doses of SRBC. Regardless 
of dose, the rates of DNA synthesis increased to a maximum on day 4. With 
the highest dose, hypersensitivity and the rate of DNA synthesis reached coin- 
cident peaks,  but with lower doses hypersensitivity developed more slowly. 
The levels reached, however, were almost equal to those achieved more quickly 
with the highest dose of SRBC. 
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FIG.  3.  Rates  of  thymidine incorporation into DNA  by popliteal lymph nodes of  mice 
inoculated in the footpad with varying doses of SRBC.  The interrupted lines represent the 
levels of DTH  measured in the contralateral footpad at the corresponding times.  Plots of 
thymidine incorporation represent means of  10 individual popliteal lymph nodes from five 
mice injected in both footpads. Plots of DTH represent the means of five mice per group. 532  DOSE AND  ROUTE  OF ANTIGEN  INJECTION OF T  CELLS 
The pattern of DNA synthesis in responding nodes showed that  a  critical 
event occurs on day 4 of the immune response to SRBC. The sudden cessation 
of cell proliferation at that time stands in contrast to the much more protracted 
cellular response in nodes or spleens stimulated with living BCG (10)  or viru- 
lent  tubercle  bacilli  (11).  The proliferative response  to  living  mycobacteria 
continues to mount until immunity brings an end to bacterial growth and kills 
most of the infecting organisms. Withdrawal of the antigenic stimulus  is  not, 
however, a likely explanation for the sudden interruption of  cell  proliferation 
that occurred coincidentally in nodes responding  to a  1,000-fold variation  in 
antigenic dose. It seems much more probable that cell proliferation is actively 
inhibited by a product of the immune response. An inhibitory agent  that pre- 
vents cell proliferation was therefore sought in the following way. 
Effect  of Intravenous  Immunization  on  the  Cellular  Response  in  a Regional 
Lymph Node.--Mice were inoculated intravenously and in one  hind  footpad 
with 109 and l0  s SRBC, respectively; the two injections were given at different 
times relative to each other. The proliferative responses in the popliteal lymph 
nodes were followed at daily intervals.  They are recorded,  together with the 
levels of DTH and peak numbers of PFC,  in Fig. 4. 
As in the observations reported by Radovich and Talmage (12), antigen given 
systemically 1 day in advance of the footpad stimulus (T_I) interfered with cell 
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FIG. 4.  (A) Levels of thymidine incorporation by popliteal lymph nodes in response to 
footpad inoculation of 10  8 SRBC in mice receiving 10  9 SRBC intravenously at different times 
relative to the footpad inoculation. The curve marked control (C) represents an animal which 
did not receive the intravenous injection of SRBC. (]3) Corresponding levels of DTH (black) 
and numbers of PFC (hatched) in popliteal lymph nodes on day 4 (time of the peak) in mice 
of the groups represented in A. Control animals (C) received only the  sensitizing footpad 
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proliferation and  PFC  production in  a  peripheral  lymph  node.  Since many 
of the cells that proliferate in response to SRBC  are T  cells  (13-15),  it  was 
not surprising that animals which showed no increase in thymidine incorpora- 
tion failed to develop DTH, but neither did animals given intravenous SRBC 1 
day after the sensitizing footpad injection, yet cell proliferation in this group 
(T+I) was substantially normal. This raised again the possibility that antigen 
injected intravenously can intercept and inhibit activated T  cells that  reach 
the circulation from nodes that  are engaged in a  seemingly normal response 
(cf. Fig. 3). The data of Fig. 2 made it quite clear, however, that mediator cells 
were not blocked by antigen given intravenously 1 day before testing for hyper- 
sensitivity.  It  seemed possible,  therefore,  that  induction  and  expression of 
DTH were blocked by different mechanisms.  In any event, blocking of cell- 
mediated immunity by intravenous antigen was clearly not an instantaneous 
process, but one requiring time in which to respond to the blocking stimulus. 
Effect  of Splenectomy  on the  Activation  of  T  Cells.--The  mechanism which 
interferes so profoundly with the activation of T  cells is obviously touched off 
more quickly by intravenous than by subcutaneous immunization. Since the 
spleen is almost exclusively involved in the immune response when SRBC are 
administered intravenously (16),  it  was  reasonable to  think  that  the  spleen 
would play a decisive role in the mechanism responsible for systemic inhibition 
of T  cells.  The data of Fig. 5 show that splenectomy, performed 3 wk before 
immunization, had a profound effect upon the response of mice to intravenous 
injection of varying doses of SRBC.  Whereas  a  small  dose  caused DTH in 
normal mice, it failed completely to sensitize the splenectomized animal; and 
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FIG. 5. Levels of DTH measured 4 days after intravenous inoculation of normal (O) and 
splenectomized (I) mice with the indicated doses of SRBC. Means of 6 -4- SE. 534  DOSE AND  ROUTE  OF ANTIGEN INJECTION OF T  CELLS 
large doses which blocked the intact animal were strongly sensitizing in splenec- 
tomized mice. The symmetry of this reciprocal relationship probably has no 
special  significance, even  though  it  is  reproducible;  it  does  show,  however, 
that the spleen is at once the major source of the cells which mediate, and of 
the factors which block, the hypersensitivity produced by intravenous immu- 
nization. The data also establish that SRBC in the intravascular compartment 
can interact inductively with T cells in the absence of the spleen, but  that the 
process is highly inefficient since it requires a stimulus almost 1,000-fold greater 
than suffices in the intact animal.  Evidently, SRBC in the vascular compart- 
ment do not have ready access  to  lymphoreticular tissues other than in the 
spleen. 
Effect  of One  Regional Response Upon A nother.--The  spleen  would  seem, 
then, to be the major cause of the abrupt interruption of T-cell activation in 
animals immunized intravenously. The experiment reported in Fig. 6 shows, 
however, that the products of the immunological response in one lymph node 
can  depress  responsiveness  in  the  contralateral  lymph node.  To  show  this 
effect to best advantage, mice were stimulated in the left footpad with one of 
two different doses of SRBC, 106 or 108. 6 days later, mice of both groups re- 
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FIG. 6.  (A) Rates of thymidine incorporation into DNA in popliteal lymph nodes on days 
3, 4, and 5 of a primary response to footpad inoculation with 10 6 SRBC (I) or 10  8 SRBC  (O). 
Incorporation rates were also measured at the same times in contralatera] nodes responding to 
a secondary stimulus of 10  8 SRBC ([D, C)) given 6 days after the primary stimulus. Separate 
groups of five mice were used for each time point. Means of 5 4- SE. (B) Histogram showing 
the corresponding numbers of direct PFC/node on days 3, 4, and 5 of primary responses to 
10 6 or 10  s SRBC, and the secondary responses to 10  8 SRBC in the contralateral lymph nodes 
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ceived a second, large antigenic stimulus (10  8 SRBC) in the contralateral foot- 
pad. Rates of thymidine incorporation  during primary and secondary responses 
were followed concurrently in mice which received both the first and second or 
only the second injection of SRBC. 
Fig. 6 A shows that high and low doses of SRBC caused cell proliferation in 
proportion to the dose (cf. Fig. 3), and had corresponding effects on the second- 
ary response  in the contralateral node.  This was severely  depressed  in both 
groups  of mice as indicated not only by thymidine incorporation  rates,  but 
even  more  conspicuously  by the  relative numbers  of  PFC  detected during 
primary and secondary responses. Whereas direct PFC production in the pop- 
liteal  lymph nodes increased progressively in animals responding  to both pri- 
mary doses of SRBC, the numbers reached  premature and much diminished 
peaks in modes responding to the secondary stimulus. The larger primary dose 
had the greater influence on both parameters of the cellular response. 
Although these findings suggest that an immune response in one lymph node 
can influence a subsequent  response in another, the possibility  exists that an- 
tigen from the footpad inoculum  could have reached  the spleen and exerted 
its inhibitory influence from there.  This is unlikely in view  Gf the fact that 
PFC levels do not increase above background in the spleens of animals immu- 
nized by footpad inoculation; but to rule  out this possibility  completely  the 
foregoing  experiment  was  repeated  in  splenectomized  mice  with  identical 
results. 
The immunological induction of cells is evidently obstructed by something 
that appears very early in the immune response. The data of Fig. 7 show that 
the suppressor is produced  in proportion to the intensity of the applied stim- 
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Fro. 7.  Levels of DTH measured in the left hind footpad 4 days after a sensitizing  inoculum 
of 10  s SRBC had been given in the right hind footpad to mice injected 2 days previously with 
the indicated intravenous doses of SRBC. One group of controls received the sensitizing foot- 
pad but not the intravenous injection of SRBC, the other received neither. Means of 10 -4- SE. 536  DOSE  AND  ROUTE  OF  ANTIGEN  INFECTION  OF  T  CELLS 
ulus: the larger the intravenous dose of SRBC the greater the reduction in the 
levels of DTH  generated  in response to a  sensitizing  injection of SRBC  (10  8) 
given 2 days later in one hind footpad. Even the dose (10 5 SRBC)  that gives 
maximum sensitization  by intravenous  immunization  caused partial  suppres- 
sion of the response to a  sensitizing injection of SRBC in the footpad. In this 
experiment hypersensitivity was measured 4 days a~ter the footpad inoculation. 
Persistence  of  DTtt  and  Response  to  a  Second  Sensitizing  Stimulus.--An 
eliciting  dose  of  10  s SRBC  was  chosen for use  throughout  these  studies  be- 
cause it represents a good sensitizing dose when injected into the footpad  (Fig. 
1).  It  was  thus  possible  to  test  for  responsiveness  to  reimmunization  in  an 
experiment  designed  to  examine  the  natural  decay of DTH.  This  was  done 
merely by performing a second footpad test 4 days after the first. In the experi- 
ment  recorded  in  Fig.  8,  mice  were  immunized  intravenously  with  10 5 or 
10  ° SRBC.  The higher  dose did not produce DTH  at  any time,  whereas  10 ~ 
SRBC  caused hypersensitivity which peaked  on day 4  and  then  decayed ex- 
ponentially.  The levels of hypersensitivity found in mice retested 4  days later 
are indicated  by the interrupted  line in Fig.  8.  Even the animals  which  were 
first  tested  on days  1  and  2  were  already refractory to  the  sensitizing  effect 
of a  test dose of SRBC. The reactions elicited in them on days 5  and  6  were 
actually  less  than  those  in  mice  being  tested  for  the  first  time  (solid  line). 
Though not recorded,  the mice immunized with  10  9 SRBC were also retested 
but failed to react. It should be emphasized that separate  groups of mice were 
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FIG. 8.  Development and decay of DTH in mice injected intravenously  with  10  5 (I) or 
10 9 SRBC (ms). The interrupted  line represents the levels of hypersensitivity  measured upon 
retest  in the contralateral  footpad 4 days after the first test for hypersensitivity.  The hori- 
zontal  line and area of hatching  represents  the mean level of DTH (4-SEM)  measured on 
day 4 in mice given only the eliciting dose of 10  8 SRBC. Animals immunized with the higher 
dose of SRBC  (10 9) were also retested but showed no evidence of DTH at either test;  only 
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used at each time point. In a similar experiment, mice were still  nonresponsive 
when tested on days 42 and 56. 
An experiment of similar design was performed in splenectomized animals. 
It showed  that hypersensitivity from an intravenous  injection  of  109  SRBC 
(a highly sensitizing dose in the absence of the spleen) decayed with a normal 
time-course (black bars, Fig. 9)  and left the animal almost nonresponsive, for 
DTH was not significantly elevated in animals tested for the second time on 
days 8 and 25  (hatched bars, Fig. 9). On the other hand,  106 SRBC produced 
very little hypersensitivity by day 4  in  splenectomized  animals,  but mice of 
this  group  reacted  strongly  when  retested  on  day 8  (hatched  bar,  Fig.  9). 
Obviously the presence of 106 SRBC in the body had not compromised the T- 
cell  responsiveness  of  splenectomized  mice  as  they  would  an  intact  mouse 
(Fig.  7).  It was significant, too, that hypersensitivity increased between days 
4  and 8, but the trend was not maintained.  Tests performed on days 14  and 
21 showed that DTH had decayed in the normal way. 
The hypersensitivity produced by the  smaller dose of SRBC  in splenecto- 
mized animals possessed another interesting feature, it was not  accompanied 
by unresponsiveness. Animals with a low but significant level of residual hyper- 
sensitivity on day 21  gave a  normal T-cell response to  the  eliciting  dose of 
SRBC  (hatched bar, day 25,  Fig. 9). This shows that activated T  cells do not 
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FIG. 9. Levels of hypersensitivity found in splenectomized mice after intravenous sensi- 
tization with 109 or 106 SRBC. The prompt onset and immediate decay of hypersensitivity 
in animals receiving the larger dose of SRBC is shown on the left (black). The retests per- 
formed in this group on days 8 and 25 showed little evidence of responsiveness (hatched). 
Animals sensitized with  the  smaller dose (right) developed sensitivity much more slowly 
(black) but responded vigorously to the eliciting dose of SRBC given on days 4 and 21. This 
is indicated by the large reactions recorded at retest on days 8 and 25 (hatched). Means of 
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interfere with the further induction of T  cells.  It also suggests that the media- 
tors of DTH are naturally short-lived cells because hypersensitivity decayed 
at  a  normal  rate  in  the  apparent  absence of the inhibitory mechanism that 
prevents animals from responding to reimmunization. 
The hemagglutinating antibody titers found in mice belonging to the groups 
represented in  Fig.  9 showed no antibody on days 4  or 21  in splenectomized 
animals immunized with 106 SRBC. Mice given 109 SRBC had not formed anti- 
body by day 4, but antibody to a titer of 1:512 was present on day 21 in these 
mice. It was all mercaptoethanol sensitive. 
DISCUSSION 
Although T  cells serve an important ancillary role in the implementation of 
most humoral response, it is uncommon to find overt evidence that antigenic 
stimulation  has caused activation of T  cells.  This is certainly so if  DTH  is 
taken as the index of T-cell activity. By this criterion, most immune responses 
would seem to be accomplished without creating significant numbers of spe- 
cifically sensitized T  cells. There are, however, some well known circumstances 
that give rise consistently to a more or less sustained state of DTH. Infection 
was such a common cause of this type of h:y2oersensitivity  that DTH was once 
known as bacterial allergy (17, 18). There are, however, some artificial ways of 
inducing  DTH.  The addition  of mycobacteria to  Freund-type adjuvants  is, 
for example, the conventional method of producing DTH (9) ; but minute doses 
of antigen, particularly when complexed with antibody, cause DTH of some- 
what  limited  duration  (7,  8);  and  macrophage-associated  (19-21)  or  macro- 
phage-processed (22)  antigens have also been found to favor the induction of 
DTH,  sometimes without evidence of antibody formation  (22).  In  contrast 
to this last finding, an ongoing response to living BCG, like that observed origi- 
nally in  tuberculous animals  by Dienes  and  Schoenheit (23),  conditions  the 
immunological apparatus for an accentuated T-cell response despite a marked 
increase in antibody production (5). 
At first sight, there is no obvious link between these diverse conditions that 
are conducive to the induction of DTH. This is another way of saying that we 
do not know what regulates the production of activated T  cells. However, the 
present investigation recalls with some emphasis what Uhr, et al. had clearly 
established (8), namely that the induction of DTH depends critically cn anti- 
genic dose  and  route  of immunization.  SRBC,  in  the  absence  cf  adjuvant, 
~-ere  found in  the  present  study to  produce DTH  even when  administered 
intravenously.  It  appeared  rapidly  and  reached  its  peak  much  earlier  than 
when Freund-D]oe adjuvants are used (1). The induction of DTH is exquisitely 
sensitive to blocking by an overdose of antigen if an adjuvant is not used. Thus 
an intravenous dose of SRBC  in the range that gives maximum antibody re- 
sponses (24) may produce no peripheral evidence of T-cell activity in the form 
of DTH  (Figs.  1 and 8).  Since splenectomy eliminates the blocking effect of P.  H.  LAGRANGE,  G.  B.  MACKANESS,  AND  T.  E.  MILLER  539 
an intravenous injection of antigen, without affecting the T-cell response  to 
SRBC injected into the footpad, it is apparent that splenectomy creates no 
dearth of competent precursor cells;  but it does remove the major source of 
antibody production (16). This points directly to a role for antibody in regulat- 
ing the participation of T cells in the immune response to SRBC, as it is known 
to have in the regulation of antibody formation (4). 
There is, however, another possibility to be considered. An intravenous in- 
jection of SRBC causes prompt withdrawal of specifically responsive lympho- 
cytes from the recirculating lymphocyte pool (25).  As a  result, thoracic duct 
lymph becomes depleted of  cells  which  can  render  irradiated recipients  re- 
sponsive to SRBC. Though it is not yet certain which cell type is most affected 
by this process of selective trapping, Rowley et al. (25) give reasons for believ- 
ing that both T  cells  and B  cells  are involved. It may be  asked, therefore, 
whether animals fail to display DTH after an excessive dose of SRBC merely 
because reactive cells are trapped in a central organ such as the spleen. This 
would explain one aspect of the observed effect of splenectomy on the induction 
of DTH.  Trapping has also been suggested (23)  as an explanation for what 
O'Toole and Davies (26) have called "pre-emption," a phenomenon in which 
peripheral  lymph nodes fail to give a  PFC response 2-4 days after injecting 
SRBC into the peritoneal cavity. It is clear from Fig. 4 that peripheral nodes 
can be suppressed even more quickly by an intravenous injection of SRBC, 
and that cell proliferation is more completely blocked than is PFC production. 
Despite  the  unequivocal  evidence  that  cells  can  be  specifically trapped, 
trapping  alone does not explain why overdosed animals show no peripheral 
evidence  of  activated T  cells.  Delayed-type hypersensitivity depends  upon 
activated lymphocytes which can function as mediators only by entering the 
blood. This means that T  cells~ though they may become trapped in central 
or peripheral  lymphoid organs during the inductive phase of an immune re- 
sponse, must give rise to effector cells  that are subsequently released to the 
circulation. The present studies show that animals previously sensitized by a 
footpad injection of SRBC  remained fully sensitive for at least 24 h  after a 
massive intravenous injection of SRBC (Fig. 2), yet the phenomenon of selec- 
tive trapping occurs within 24 h of injecting antigen (25). It can be concluded, 
therefore, that specifically sensitized lymphocytes, once formed, are not sub- 
ject to specific trapping by antigen alone. This conclusion is supported by the 
fact that cells  which can  support  an immune response  to SRBC  have been 
shown to reappear and be fully represented in central lymph 4 days after an 
intravenous injection of  SRBC  (25).  At  this time, DTH remains fully sup- 
pressed in mice immunized intravenously with a  comparable dose of SRBC 
(Figs. 1, 5,  and 8).  This means that the trapping which occurs in a primary 
immune response affects precursor cells only, and is a temporary event which 
is probably limited to the period of blast transformation and cell division that 
give rise to specifically sensitized lymphocytes (11). Hall and Morris (27) have 540  DOSE  AND  ROUTE  OF  ANTIGEN  INJECTION  OF  T  CELLS 
shown that there is, in fact, an initial fall in the output of cells from a region- 
ally stimulated node. It ends with a massive release of blast cells to the efferent 
lymphatics  (28). No doubt this efltux of cells includes the specific mediators 
of DTH which are known to b e represented in central lymph (29). It is per- 
tinent, too, that a subcutaneous injection of SRBC in Freund's complete ad- 
juvant caused the same selective removal of reactive cells from central lymph 
(25), yet DTH appeared in due course. Obviously, the cells that mediate DTH 
reactions are not retained for long at the site of the primary immune response 
whether this occurs centrally or in peripheral lymphoid tissues. 
The ease with which a small excess of antigen can interfere with the induction 
of a T-cell response (Fig. 7) raises a question concerning the interpretation of 
findings such as those of Pearson and Raffel  (22)  or of Parish  (30,  31).  The 
former showed that as SRBC become degraded after ingestion by macrophages 
they gain progressively in their ability to induce DTH, but lose activity as a 
stimulus  to  antibody production.  Pafish's  observations  show  that  chemical 
modification of SRBC (30) or flagellin (31) has a similar effect on antigenicity. 
In light of the present observations, these effects of antigen "processing" may 
be no more than would be expected from lowering the dose of antigen, or render- 
ing a given dose less antigenic. 
It is reported in the folkrwing paper (32) that antigen and antibody are both 
involved in regulating T-cell activity. Antigen which reaches the  circulation 
provides not only a  powerful stimulus  to  antibody formation by the  spleen 
but is immediately available to interact with antibody and create factors that 
interfere  with  effector cells  which  circulate  in  the  vascular  compartment. 
There are, therefore, two reasons why DTH is difficult to induce by immuniz- 
ing procedures that permit antigen to gain access to the circulation. 
SUMMARY 
Delayed-type hypersensitivity (DTH) develops in the  absence of an adju- 
vant when mice are injected intravenously or subcutaneously with an appro- 
priate dose of sheep red blood cells (SRBC). The optimal intravenous dose of 
10  ~  SRBC (in CD-1 mice) produces maximum DTH which decays exponentially 
from its peak on day 4.  Increasing the dose of SRBC reduces and eventually 
abolishes all evidence of DTH. DTH fails to reappear in respose to secondary 
stimulation except in  splenectomized mice in whom the development of DTH 
is  not  suppressed,  even by massive  doses  of SRBC.  Hence the  suppression 
cannot be due to antigen as such. 
The optimal dose of  SRBC for sensitization by footpad inoculation is 100- 
fold higher (107 SRBC in CD-1  mice), but even  109 SRBC do not block the 
induction of DTH by this route of immunization. A blocking dose  of SRBC, 
given intravenously 1 day before footpad inoculation,  completely suppresses 
cell proliferation in the draining lymph node, prevents PFC production there, 
and blocks the induction of DTH by a  sensitizing dose of SRBC.  If given 1 P. If. LAGRANGE~  G. B. MACKANESS,  AND  T. ]~. MILLER  541 
day  after footpad  sensitization,  intravenous  antigen  has  little  effect on  the 
cellular response in the regional node but DTH is still completely suppressed. 
Blocking  of  induction  and  expression  may  depend,  therefore,  on  different 
mechanisms. 
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